Get started
Author

Chiara Astrua

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium
2017 · P. Quaglino, M. Maule, et al. · Annals of Oncology · 137
PDF
Radiotherapy and immune checkpoints inhibitors for advanced melanoma
2016 · Andrea Riccardo Filippi, Paolo Fava, et al. · Radiotherapy and Oncology · 77
Ipilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: Effectiveness and toxicity management
2016 · Paola Savoia, Chiara Astrua, et al. · Human Vaccines & Immunotherapeutics · 72
PDF
Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients
2020 · Davide Zocco, Simona Bernardi, et al. · Scientific Reports · 66
PDF
Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients
2013 · S. Ribero, S. Osella-Abate, et al. · British Journal of Dermatology · 60
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab
2015 · S. Valpione, C. Martinoli, et al. · European Journal of Cancer · 51
PDF
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome
2020 · Pietro Quaglino, Paolo Fava, et al. · Journal of Investigative Dermatology · 43
PDF
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup
2016 · William Bruno, Lorenza Pastorino, et al. · Journal of the American Academy of Dermatology · 41
PDF
Complete regression of melanoma skin metastases after electrochemotherapy plus ipilimumab treatment: an unusual clinical presentation
2015 · Matteo Brizio, Paolo Fava, et al. · European Journal of Dermatology · 39
Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease
2017 · Alessandro Pileri, Claudio Agostinelli, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 28
Corrections to “Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium”
2018 · P. Quaglino, M. Maule, et al. · Annals of Oncology · 27
PDF
Cutaneous adverse reactions following SARS‐CoV ‐2 vaccine booster dose: a real‐life multicentre experience
2022 · G. Avallone, F. Cavallo, et al. · Journal of the European Academy of Dermatology and Venereology · 23
PDF
miR‐155 expression in Primary Cutaneous T‐Cell Lymphomas (CTCL)
2016 · P. Fava, M. Bergallo, et al. · Journal of the European Academy of Dermatology and Venereology · 21
Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas
2015 · Paolo Fava, Massimiliano Bergallo, et al. · Dermatology · 21
PDF
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort
2019 · Cristina Pellegrini, Francesca Botta, et al. · The Lancet Child & Adolescent Health · 20
PDF
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real‐life Italian multicenter observational study of 250 patients
2024 · Gianluca Nazzaro, Andrea Carugno, et al. · International Journal of Dermatology · 19
PDF
Bexarotene as maintenance treatment after therapies other than skin‐directed therapy in advanced‐stage mycosis fungoides: a pilot study
2019 · A. Pileri, P. Fava, et al. · Journal of the European Academy of Dermatology and Venereology · 12
Treatment of metastatic melanoma: a multidisciplinary approach
2017 · Paolo Fava, Chiara Astrua, et al. · Italian Journal of Dermatology and Venereology · 11
Reply to ‘The first dose of COVID‐19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?’ by Damiani G et al.
2022 · G. Avallone, S. Giordano, et al. · Journal of the European Academy of Dermatology and Venereology · 8
Drug Survival and Clinical Course of Patients with Cancer Treated with Biologic Therapy for Psoriasis
2024 · Nicole Macagno, Luca Mastorino, et al. · Journal of Clinical Medicine · 7
PDF
Advances in the pharmacological management of cutaneous T-cell lymphoma
2024 · Gabriele Roccuzzo, Andrea Roggo, et al. · Expert Opinion on Pharmacotherapy · 7
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study
2022 · Pietro Quaglino, Mauro Novelli, et al. · Disease Markers · 7
PDF
Real-Life Outcomes of Adjuvant Targeted Therapy and Anti-PD1 Agents in Stage III/IV Resected Melanoma
2024 · Gabriele Roccuzzo, Paolo Fava, et al. · Cancers · 6
PDF
A study of melanoma in Eastern European migrants in Italy
2017 · Chiara Astrua, Paolo Fava, et al. · European Journal of Dermatology · 6
Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature
2014 · P. Fava, C. Astrua, et al. · Journal of the European Academy of Dermatology and Venereology · 6
PDF
Works count: 52
Citation count: 849
H-index: 16
I10-index: 18
Year
Topic
Type